当前位置: X-MOL 学术Org. Biomol. Chem. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Synthesis of plasmodione metabolites and 13C-enriched plasmodione as chemical tools for drug metabolism investigation†
Organic & Biomolecular Chemistry ( IF 2.9 ) Pub Date : 2018-03-06 00:00:00 , DOI: 10.1039/c8ob00227d
Liwen Feng 1, 2, 3, 4, 5 , Don Antoine Lanfranchi 1, 2, 3, 4, 5 , Leandro Cotos 1, 2, 3, 4, 5 , Elena Cesar-Rodo 1, 2, 3, 4, 5 , Katharina Ehrhardt 5, 6, 7, 8, 9 , Alice-Anne Goetz 5, 6, 7, 8, 9 , Herbert Zimmermann 10, 11, 12, 13 , François Fenaille 5, 14, 15, 16 , Stephanie A. Blandin 5, 6, 7, 8, 9 , Elisabeth Davioud-Charvet 1, 2, 3, 4, 5
Affiliation  

Malaria is a tropical parasitic disease threatening populations in tropical and sub-tropical areas. Resistance to antimalarial drugs has spread all over the world in the past 50 years, thus new drugs are urgently needed. Plasmodione (benzylmenadione series) has been identified as a potent antimalarial early lead drug, acting through a redox bioactivation on asexual and young sexual blood stages. To investigate its metabolism, a series of plasmodione-based tools, including a fully 13C-labelled lead drug and putative metabolites, have been designed and synthesized for drug metabolism investigation. Furthermore, with the help of UHPLC-MS/MS, two of the drug metabolites have been identified from urine of drug-treated mice.

中文翻译:

疟原虫二酮代谢物和富含13 C的疟原虫二酮的合成作为药物代谢研究的化学工具

疟疾是一种热带寄生虫病,威胁着热带和亚热带地区的居民。在过去的50年中,抗疟药的耐药性已遍及世界各地,因此迫切需要新药。疟原虫(苄基甲二酮系列)已被确认为有效的抗疟疾早期先导药物,通过对无性和年轻性血液阶段的氧化还原生物激活而发挥作用。为了研究其代谢,已设计并合成了一系列基于血浆二酮的工具,包括完全13 C标记的先导药物和推定的代谢物,以进行药物代谢研究。此外,借助UHPLC-MS / MS,已从经药物治疗的小鼠的尿液中鉴定出两种药物代谢物。
更新日期:2018-03-06
down
wechat
bug